Intellia Drops Counterclaims In Gene-Editing Patent Case
By Elliot Weld · May 20, 2026, 5:05 PM EDT
Intellia Therapeutics Inc. has agreed to drop a set of claims it asserted in a Delaware federal suit brought by BlueAllele, which accused it of infringing three gene-editing patents to bring...
To view the full article, register now.